Bio-Rad Laboratories, Inc.
BIONYSEHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $9.75B
- P/E (TTM)
- 43.83
- Forward P/E
- 63.16
- Dividend yield
- -
- 52-week range
- $236.73$396.23
- Volume (live)
- -
- Avg. volume (3M)
- 262.72K
Bio-Rad Laboratories (BIO) Stock Price & Financial Analysis
Bio-Rad Laboratories Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $359.83 - $367.93 |
|---|---|
| 52-Week High | $396.23 |
| 52-Week Low | $236.73 |
| Open | $359.83 |
| Volume (last close) | 228.22K |
| Average Volume (3M) | 262.72K |
| Revenue (TTM) | 2.59B |
|---|---|
| Net Income (TTM) | 222.40M |
| Free Cash Flow (TTM) | 353.10M |
| EPS (TTM) | $8.26 |
| Profit Margin | 8.59% |
| Operating Margin | 9.03% |
| Return on Equity (ROE) | 3.10% |
| Debt to Equity | 0.17 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 9.75B |
|---|---|
| Shares Outstanding | 26.81M |
| P/E Ratio (TTM) | 43.83 |
| Forward P/E | 63.16 |
| Price to Sales (P/S) | 3.76 |
| Price to Book (P/B) | 1.36 |
| EV/EBITDA | 9.80 |
| 50-Day MA | $372.71 |
|---|---|
| 200-Day MA | $311.36 |
| 1-Year Change | +7.33% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Bio-Rad Laboratories at a Glance
As of the Oct 22, 2026 close, Bio-Rad Laboratories (BIO) has a market capitalization of $9.75B. The stock trades at 43.8× trailing earnings, 63.2× forward earnings and 3.8× sales. Over the trailing twelve months it earned $222.40M on revenue of $2.59B (a 8.6% profit margin) and generated $353.10M of free cash flow. Revenue grew 1.4% year over year.
As of its latest reported balance sheet, it holds $517.00M in cash and securities against $1.20B of debt, a net debt position of $686.70M.
Bio-Rad Laboratories does not currently pay a dividend.
The share price is up 7.3% over the past year. At $363.50 (the Oct 22, 2026 close) it sits within its 52-week range of $236.73 to $396.23, above its 200-day moving average of $311.36.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Bio-Rad Laboratories
What is the current stock price for BIO?
As of the Oct 22, 2026 close, BIO stock trades at $363.50. The 52-week range is $236.73–$396.23, with a day range of $359.83–$367.93.
What is the P/E ratio for BIO?
As of the Oct 22, 2026 close, Bio-Rad Laboratories's trailing twelve-month (TTM) P/E ratio is 43.8, meaning investors pay $43.8 for every $1 of annual earnings. The forward P/E is 63.2, reflecting analyst expectations for future earnings. Bio-Rad Laboratories operates in the Healthcare sector.
Does BIO pay dividends?
Bio-Rad Laboratories does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for BIO?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for BIO is Buy.
What is the market cap of BIO?
As of the Oct 22, 2026 close, Bio-Rad Laboratories's market capitalization is $9.75B, classifying it as a mid-cap company. Bio-Rad Laboratories operates in the Healthcare sector within the Medical Devices industry.